Extended Data Fig. 2: Additional analysis of genomic correlates of response to anti-PD-1 immunotherapy.
From: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
a, Mutation burden by response group (n = 17 patients). b, Tumor purity, as estimated by ABSOLUTE, by response group. c, Ratio of subclonal to clonal mutations, as estimated by ABSOLUTE, by response group. d, Aneuploidy score analysis of non-responders versus responders. Boxplots show the median, interquartile range, and whiskers (1.5 times interquartile range).
